New dual-gold complex has preclinical, multifaceted activity against drug-resistant cancer cells
Feb. 28, 2025
In a recently published study, researchers from Shandong Second Medical University and collaborators synthesized a new dual-gold(I) complex, named QB-1561, and tested its potential to inhibit drug-resistant cancer cells overexpressing ATP-binding cassette (ABC) transporters